These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 3481323)
21. Decrease of caffeine elimination in man during co-administration of 4-quinolones. Stille W; Harder S; Mieke S; Beer C; Shah PM; Frech K; Staib AH J Antimicrob Chemother; 1987 Nov; 20(5):729-34. PubMed ID: 3480885 [TBL] [Abstract][Full Text] [Related]
22. Clinical uses of nalidixic acid analogues: the fluoroquinolones. Høiby N Eur J Clin Microbiol; 1986 Apr; 5(2):138-40. PubMed ID: 3013628 [No Abstract] [Full Text] [Related]
23. The influence of the 4-quinolones ciprofloxacin, pefloxacin and ofloxacin on the elimination of theophylline. Wijnands WJ; Vree TB; Baars AM; van Herwaarden CL Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S72-5. PubMed ID: 3481439 [TBL] [Abstract][Full Text] [Related]
27. [Therapeutic drug monitoring of fluoroquinolone]. Matsumoto F; Takahashi T; Morita M Nihon Rinsho; 1990 Feb; 48 Suppl():1217-22. PubMed ID: 2355524 [No Abstract] [Full Text] [Related]
28. Pharmacokinetics of fluorinated 4-quinolones in the aged. Norrby SR; Ljungberg B Rev Infect Dis; 1989; 11 Suppl 5():S1102-6. PubMed ID: 2672244 [TBL] [Abstract][Full Text] [Related]
29. A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora. Edlund C; Nord CE Infection; 1988; 16(1):8-12. PubMed ID: 3283041 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of quinolones in renal insufficiency. Fillastre JP; Leroy A; Moulin B; Dhib M; Borsa-Lebas F; Humbert G J Antimicrob Chemother; 1990 Oct; 26 Suppl B():51-60. PubMed ID: 2124213 [TBL] [Abstract][Full Text] [Related]